Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
<p><strong>Introduction:</strong><br /> The lack of approved specific therapeutic agents to treat coronavirus disease (COVID‐19) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has led to the rapid implementation of convalescent plasma t...
Κύριοι συγγραφείς: | Harvala, H, Robb, ML, Watkins, N, Ijaz, S, Dicks, S, Patel, M, Supasa, P, Wanwisa, D, Liu, C, Mongkolsapaya, J, Bown, A, Bailey, D, Vipond, R, Grayson, N, Temperton, N, Gupta, S, Ploeg, RJ, Bolton, J, Fyfe, A, Gopal, R, Simmonds, P, Screaton, G, Thompson, C, Brooks, T, Zambon, M, Miflin, G, Roberts, DJ |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Wiley
2020
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
The molecular reach of antibodies crucially underpins their viral neutralisation capacity
ανά: Anna Huhn, κ.ά.
Έκδοση: (2025-01-01) -
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
ανά: Thompson, CP, κ.ά.
Έκδοση: (2020) -
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
ανά: Emma M. Bentley, κ.ά.
Έκδοση: (2021-08-01) -
Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
ανά: Samantha K Davis, κ.ά.
Έκδοση: (2022-01-01) -
Effects of SARS-CoV-2 strain variation on virus neutralisation titres: therapeutic use of convalescent plasma
ανά: Nguyen, D, κ.ά.
Έκδοση: (2021)